GlassScriptPhysician profile
Reyna Caraccioli
NPI 1396470605
$2,095.11
in general payments reported to CMS, 2019-2025
18 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $232 · 2023: $1,243 · 2024: $114 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $382.21 | 2023-2025 | Austedo Xr, Uzedy |
| Alexion Pharmaceuticals, INC. | $243.66 | 2022-2025 | Strensiq |
| Regeneron Healthcare Solutions, INC. | $133.65 | 2023 | Dupixent |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Gemtesa |
| Dermavant Sciences, INC. | $124.99 | 2023 | Vtama |
| Sanofi Pasteur INC. | $124.97 | 2023 | |
| Novo Nordisk INC | $123.47 | 2022 | |
| Xeris Pharmaceuticals, INC. | $121.87 | 2023 | Gvoke Hypopen |
| Genzyme Corporation | $118.54 | 2023 | |
| Sage Therapeutics, LLC | $118.36 | 2023 | |
| Stryker Corporation | $102.54 | 2025 | Surgicount |
| Ucb, INC. | $96.24 | 2023 | Fintepla |
| Lilly USA, LLC | $95.43 | 2024 | Zepbound |
| Dexcom, INC. | $85.93 | 2023 | Dexcom G7 Gss (161) |
| Exact Sciences Corporation | $51.68 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $18.64 | 2024 | Xiaflex |
| Boston Scientific Corporation | $14.32 | 2025 | Spyglass Discover |
| Pacira Pharmaceuticals Incorporated | $13.61 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reyna Caraccioli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.